Fulcrum Capital »

Vertex Pharmaceuticals Incorporated shares owned by Fulcrum Capital

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Fulcrum Capital from 13F filings

Historical chart of Fulcrum Capital investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Fulcrum Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Fulcrum Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.4M 15k 418.01
2023-12-31 $6.1M 15k 406.89
2023-09-30 $5.5M 16k 347.74
2023-06-30 $5.6M 16k 351.91
2023-03-31 $5.3M 17k 315.07
2022-12-31 $3.9M 14k 288.78
2022-09-30 $993k 3.4k 289.67
2022-06-30 $1.1M 3.7k 281.81

More positions owned by Fulcrum Capital

Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Mastercard Incorporated Cl A (MA)
Trane Technologies SHS (TT)
Adobe Systems Incorporated (ADBE)
Edwards Lifesciences (EW)
JPMorgan Chase & Co. (JPM)
Waste Management (WM)
UnitedHealth (UNH)
Cme (CME)

View all positions for Fulcrum Capital

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
T. Rowe Price Associates
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated